In the MPS field, the TBG promoter has been shown to enhance bone length in MPS VI feline and rat models [83,84], leading to ongoing clinical trials for MPS VI using a liver-specific promoter in an AAV8 vector (NCT03173521) [85]. The gene discussed is SERPINA7; the disease is mucopolysaccharidosis.